Echovirus is a type of virus that resides in the gastrointestinal (GI) tract. These viruses are collectively called Enteroviruses and are second only to rhinoviruses in prevalence. Echovirus derives its name from the ECHO (Enteric Cytopathic Human Orphan) virus. Generally, newborns, children, and young people are vulnerable to echovirus, as adults are more likely to have a developed immunity system; however, they can still become infected. Common symptoms of echovirus infection are cough, sore throat, flu, and rashes. Other symptoms include viral meningitis (that causes intense fever, chills, nausea, vomiting, and headache), myocarditis, encephalitis, and neonatal sepsis. There are no particular control measures or medicines for echovirus since its spread is infectious. However, it can be averted through executing great cleanliness practices and avoidance of shared utensils which may interfere with the transmission of the virus. A quick analysis of such viruses can help the patient from unnecessary treatment and lessen the length of hospitalization, thus reducing the overall expenditure for the treatment.
Major factors driving the global include rise in prevalence of echovirus infection among all ages of people due to its transmissible nature, technological advancements in molecular diagnostic techniques, and bioterrorism and availability of immunosuppressive drugs in a wide range. According to the CDC (Centers for Disease Control and Prevention), it has been estimated that around 12-14 million cases of symptomatic enterovirus infections are found in the U.S. every year. This means that infections with echovirus and enteroviruses are highly prevalent. In the U.S., the infection is more common during the summer and autumn seasons. Moreover, increase in government health programs, especially in developing nations, is expected to promote the echovirus diagnostics market in these regions.
Request to View Brochure of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1597
Usually, echovirus infections are mild in nature and there are no specific treatment available for them. Thus, special tests are not performed for the diagnosis of Echovirus. Echovirus can be confirmed through laboratory tests, such as, rectal culture, stool culture, throat culture, and a spinal fluid culture. Segmentation of the echovirus diagnostics market can be done based on the clinical application, end-user and geography. On the basis of clinical application, the echovirus diagnostics market can be categorized into molecular diagnostics, immunoassays, differential light scattering, information technology, liposomes, flow cytometry, chromatography, gel micro-droplets, diagnostic imaging, monoclonal antibodies, and others. In terms of end-user, the echovirus diagnostics market can be divided into hospitals, commercial/private laboratories, physician offices, and public health labs.
On the basis of geography, the global echovirus diagnostics market can be distributed among five regions, viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the leading share of the echovirus diagnostics market in 2017, followed by Europe. This can be attributed to the presence of a large number of leading echovirus diagnostics market players, technological advancements, and high health care expenditure in North America. In Europe, initiatives taken by the government in research & development are likely to drive the echovirus diagnostics market. Emerging countries of Asia Pacific are expected to witness high growth in the echovirus diagnostics market due to high prevalence of infections, large patient population, and developing health care technology. However, the developing nations of the Middle East and Latin America are expected to witness a sluggish growth due to poor health care facilities and limited investment in research and development.
Key players operating in the global echovirus diagnostics market include Abbott Laboratories, Inc., Gen-Probe, Inc., Danaher Corporation, Becton Dickinson and Company, Novartis Diagnostics, Qiagen, F. Hoffmann-La Roche Ltd., Siemens Ltd., Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Inc., and Wallac OY.
Request to View ToC of the report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1597
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Website